Jaromir Mikl

656 total citations
24 papers, 445 citations indexed

About

Jaromir Mikl is a scholar working on Infectious Diseases, Psychiatry and Mental health and Epidemiology. According to data from OpenAlex, Jaromir Mikl has authored 24 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Psychiatry and Mental health and 6 papers in Epidemiology. Recurrent topics in Jaromir Mikl's work include HIV/AIDS Research and Interventions (8 papers), HIV Research and Treatment (5 papers) and Adolescent Sexual and Reproductive Health (4 papers). Jaromir Mikl is often cited by papers focused on HIV/AIDS Research and Interventions (8 papers), HIV Research and Treatment (5 papers) and Adolescent Sexual and Reproductive Health (4 papers). Jaromir Mikl collaborates with scholars based in United States, Argentina and United Kingdom. Jaromir Mikl's co-authors include William S. Burnett, Philip C. Nasca, Perry F. Smith, Dale L. Morse, Barbara K. Burton, Simon Jones, Alan R. Kristal, Alison Muse, Benedict I. Truman and Roy W. Stevens and has published in prestigious journals such as PLoS ONE, American Journal of Epidemiology and American Journal of Public Health.

In The Last Decade

Jaromir Mikl

23 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaromir Mikl United States 12 165 139 88 80 64 24 445
Yanxiao Gao China 13 159 1.0× 167 1.2× 30 0.3× 32 0.4× 94 1.5× 37 483
Niloufar Ameli United States 13 155 0.9× 230 1.7× 80 0.9× 59 0.7× 73 1.1× 27 651
X. de la Tribonnière France 12 172 1.0× 256 1.8× 29 0.3× 44 0.6× 46 0.7× 40 545
Alexandra Hernández United States 11 92 0.6× 64 0.5× 42 0.5× 182 2.3× 82 1.3× 50 598
Ranjababu Kulasegaram United Kingdom 19 392 2.4× 526 3.8× 41 0.5× 102 1.3× 40 0.6× 66 1.0k
Zoë R. Greenwald Canada 12 274 1.7× 218 1.6× 43 0.5× 123 1.5× 51 0.8× 28 531
Mingshan Xue China 16 80 0.5× 192 1.4× 95 1.1× 39 0.5× 25 0.4× 50 602
Helen Koenig United States 12 232 1.4× 256 1.8× 16 0.2× 198 2.5× 122 1.9× 32 866
Ricardo Andrade Carmo Brazil 14 263 1.6× 173 1.2× 33 0.4× 23 0.3× 71 1.1× 33 503
Marianne Maynard France 12 513 3.1× 76 0.5× 35 0.4× 60 0.8× 33 0.5× 44 740

Countries citing papers authored by Jaromir Mikl

Since Specialization
Citations

This map shows the geographic impact of Jaromir Mikl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaromir Mikl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaromir Mikl more than expected).

Fields of papers citing papers by Jaromir Mikl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaromir Mikl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaromir Mikl. The network helps show where Jaromir Mikl may publish in the future.

Co-authorship network of co-authors of Jaromir Mikl

This figure shows the co-authorship network connecting the top 25 collaborators of Jaromir Mikl. A scholar is included among the top collaborators of Jaromir Mikl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaromir Mikl. Jaromir Mikl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mikl, Jaromir, et al.. (2024). Drivers and Barriers to Tolerable and Effective Treatment for ADHD: The Importance of Treatment Perseverance and Duration of Effect. Journal of Attention Disorders. 28(3). 310–320. 1 indexed citations
3.
Lee, Lulu, et al.. (2023). The Burden of Attention-Deficit/Hyperactivity Disorder in Adults. The Primary Care Companion For CNS Disorders. 25(2). 1 indexed citations
4.
Donnelly, Graeme, et al.. (2022). Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD. Journal of Attention Disorders. 26(14). 1870–1881. 5 indexed citations
5.
Cambron‐Mellott, M. Janelle, et al.. (2021). Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment. Patient Preference and Adherence. Volume 15. 1061–1073. 5 indexed citations
6.
Harrington, Magdalena, Asha Hareendran, Anne Skalicky, et al.. (2019). Assessing the impact on caregivers caring for patients with rare pediatric lysosomal storage diseases: development of the Caregiver Impact Questionnaire. Journal of Patient-Reported Outcomes. 3(1). 44–44. 15 indexed citations
7.
Vernon, Margaret, et al.. (2018). Validation of the shortened Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS). Health and Quality of Life Outcomes. 16(1). 209–209. 5 indexed citations
8.
Chen, Liuxi, Jaromir Mikl, Ryan M. Fryer, et al.. (2017). A Multiplatform Approach for the Discovery of Novel Drug-Induced Kidney Injury Biomarkers. Chemical Research in Toxicology. 30(10). 1823–1834. 2 indexed citations
9.
Stults, Cheryl L. M., et al.. (2014). A Risk-Based Approach to Management of Leachables Utilizing Statistical Analysis of Extractables. AAPS PharmSciTech. 16(2). 315–326. 5 indexed citations
10.
Salazar, Juan C., Pedro Cahn, Marinella Della Negra, et al.. (2013). Efficacy and Safety of Tipranavir Coadministered with Ritonavir in HIV-1-Infected Children and Adolescents. The Pediatric Infectious Disease Journal. 33(4). 396–400. 4 indexed citations
11.
Mikl, Jaromir, Mark Sulkowski, Yves Benhamou, et al.. (2009). Hepatic profile analyses of tipranavir in Phase II and III clinical trials. BMC Infectious Diseases. 9(1). 203–203. 12 indexed citations
12.
Salazar, Juan C., Pedro Cahn, Ram Yogev, et al.. (2008). Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents. AIDS. 22(14). 1789–1798. 29 indexed citations
13.
Mikl, Jaromir, et al.. (1998). HIV infection and high risk behavior among patients attending an STD referral clinic in Prague, Czech Republic. Sexually Transmitted Infections. 74(2). 128–130. 12 indexed citations
14.
Muse, Alison, Jaromir Mikl, & Perry F. Smith. (1995). Evaluating the quality of anonymous record linkage using deterministic procedures with the New York state aids registry and a hospital discharge file. Statistics in Medicine. 14(5-7). 499–509. 27 indexed citations
15.
Chang, Hwa‐Gan H., et al.. (1993). Survival and Mortality Patterns of an Acquired Immunodeficiency Syndrome (AIDS) Cohort in New York State. American Journal of Epidemiology. 138(5). 341–349. 40 indexed citations
16.
Smith, Perry F., et al.. (1991). The AIDS epidemic in New York State.. American Journal of Public Health. 81(Suppl). 54–60. 8 indexed citations
17.
Mikl, Jaromir, Benedict I. Truman, J. Stan Lehman, et al.. (1991). HIV infection among women entering the New York State correctional system.. American Journal of Public Health. 81(Suppl). 35–40. 53 indexed citations
18.
Morse, Dale L., Benedict I. Truman, John P. Hanrahan, et al.. (1990). AIDS behind bars. Epidemiology of New York State prison inmate cases, 1980-1988.. PubMed. 90(3). 133–8. 14 indexed citations
19.
Burnett, William S., et al.. (1989). Cancer among New York men at risk of acquired immunodeficiency syndrome. International Journal of Cancer. 43(6). 979–985. 80 indexed citations
20.
Kristal, Alan R., Philip C. Nasca, William S. Burnett, & Jaromir Mikl. (1988). CHANGES IN THE EPIDEMIOLOGY OF NON-HODGKIN'S LYMPHOMA ASSOCIATED WITH EPIDEMIC HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION. American Journal of Epidemiology. 128(4). 711–718. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanxiao Gao Breakdown of academic impact, for papers by Niloufar Ameli Breakdown of academic impact, for papers by X. de la Tribonnière Breakdown of academic impact, for papers by Alexandra Hernández Breakdown of academic impact, for papers by Ranjababu Kulasegaram Breakdown of academic impact, for papers by Zoë R. Greenwald Breakdown of academic impact, for papers by Mingshan Xue Breakdown of academic impact, for papers by Helen Koenig Breakdown of academic impact, for papers by Ricardo Andrade Carmo Breakdown of academic impact, for papers by Marianne Maynard
Rankless by CCL
2026